99 related articles for article (PubMed ID: 8146313)
1. The effect of two topoisomerase inhibitors on low-dose hypersensitivity and increased radioresistance in Chinese hamster V79 cells.
Skov K; Zhou H; Marples B
Radiat Res; 1994 Apr; 138(1 Suppl):S117-20. PubMed ID: 8146313
[TBL] [Abstract][Full Text] [Related]
2. Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells.
Holm C; Covey JM; Kerrigan D; Pommier Y
Cancer Res; 1989 Nov; 49(22):6365-8. PubMed ID: 2553254
[TBL] [Abstract][Full Text] [Related]
3. The effect of oxygen on low-dose hypersensitivity and increased radioresistance in Chinese hamster V79-379A cells.
Marples B; Joiner MC; Skov KA
Radiat Res; 1994 Apr; 138(1 Suppl):S17-20. PubMed ID: 8146317
[TBL] [Abstract][Full Text] [Related]
4. The response of Chinese hamster V79-379A cells exposed to negative pi-mesons: evidence that increased radioresistance is dependent on linear energy transfer.
Marples B; Lam GK; Zhou H; Skov KA
Radiat Res; 1994 Apr; 138(1 Suppl):S81-4. PubMed ID: 8146334
[TBL] [Abstract][Full Text] [Related]
5. Complex response of breast epithelial cell lines to topoisomerase inhibitors.
Davis PL; Shaiu WL; Scott GL; Iglehart JD; Hsieh TS; Marks JR
Anticancer Res; 1998; 18(4C):2919-32. PubMed ID: 9713486
[TBL] [Abstract][Full Text] [Related]
6. The elimination of low-dose hypersensitivity in Chinese hamster V79-379A cells by pretreatment with X rays or hydrogen peroxide.
Marples B; Joiner MC
Radiat Res; 1995 Feb; 141(2):160-9. PubMed ID: 7838954
[TBL] [Abstract][Full Text] [Related]
7. Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864).
Mattern MR; Hofmann GA; McCabe FL; Johnson RK
Cancer Res; 1991 Nov; 51(21):5813-6. PubMed ID: 1657371
[TBL] [Abstract][Full Text] [Related]
8. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
9. Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase I.
Gupta RS; Gupta R; Eng B; Lock RB; Ross WE; Hertzberg RP; Caranfa MJ; Johnson RK
Cancer Res; 1988 Nov; 48(22):6404-10. PubMed ID: 2846151
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.
Bowman KJ; Newell DR; Calvert AH; Curtin NJ
Br J Cancer; 2001 Jan; 84(1):106-12. PubMed ID: 11139322
[TBL] [Abstract][Full Text] [Related]
11. Small doses of high-linear energy transfer radiation increase the radioresistance of Chinese hamster V79 cells to subsequent X irradiation.
Marples B; Skov KA
Radiat Res; 1996 Oct; 146(4):382-7. PubMed ID: 8927710
[TBL] [Abstract][Full Text] [Related]
12. Schedule-dependent cytotoxicity of topotecan alone and in combination chemotherapy regimens.
Cheng MF; Chatterjee S; Berger NA
Oncol Res; 1994; 6(6):269-79. PubMed ID: 7865902
[TBL] [Abstract][Full Text] [Related]
13. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
[TBL] [Abstract][Full Text] [Related]
14. Additive and supraadditive interaction between ionizing radiation and pazelliptine, a DNA topoisomerase inhibitor, in Chinese hamster V-79 fibroblasts.
Balosso J; Giocanti N; Favaudon V
Cancer Res; 1991 Jun; 51(12):3204-11. PubMed ID: 1645614
[TBL] [Abstract][Full Text] [Related]
15. The response of Chinese hamster V79 cells to low radiation doses: evidence of enhanced sensitivity of the whole cell population.
Marples B; Joiner MC
Radiat Res; 1993 Jan; 133(1):41-51. PubMed ID: 8434112
[TBL] [Abstract][Full Text] [Related]
16. Induction of genotoxic and cytotoxic damage by aclarubicin, a dual topoisomerase inhibitor.
Hajji N; Mateos S; Pastor N; Domínguez I; Cortés F
Mutat Res; 2005 May; 583(1):26-35. PubMed ID: 15866463
[TBL] [Abstract][Full Text] [Related]
17. Drastic reduction of topoisomerase II alpha associated with major acquired resistance to topoisomerase II active agents but minor perturbations of cell growth.
Hashimoto S; Chatterjee S; Ranjit GB; Bao C; Ford J; Ganapathi R; Berger SJ; Berger NA
Oncol Res; 1995; 7(7-8):407-16. PubMed ID: 8747604
[TBL] [Abstract][Full Text] [Related]
18. Modulation of radiation response by inhibiting topoisomerase II catalytic activity.
Mateos S; Hajji N; Pastor N; Cortés F
Mutat Res; 2006 Jul; 599(1-2):105-15. PubMed ID: 16574164
[TBL] [Abstract][Full Text] [Related]
19. DNA repair and cell cycle interactions in radiation sensitization by the topoisomerase II poison etoposide.
Giocanti N; Hennequin C; Balosso J; Mahler M; Favaudon V
Cancer Res; 1993 May; 53(9):2105-11. PubMed ID: 8386982
[TBL] [Abstract][Full Text] [Related]
20. Suppression of the radiation-sensitive phenotype of hamster irs1 and irs2 strains selected for resistance to 3-aminobenzamide.
Ganesh A; Phillips E; Thacker J; Meuth M
Int J Radiat Biol; 2001 May; 77(5):609-16. PubMed ID: 11382339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
